Clene (CLNN) CFO Morgan Brown Buys 15,000 Shares
CLNN's CFO, Morgan Brown, purchased 15,000 shares on June 11, 2026.
Reviewed by automated data checks against the source filing. How we make and check alerts
Morgan Brown, Chief Financial Officer at Clene Inc. ($CLNN), bought 15,000 shares on June 11, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $CLNN is up 8.7% after 1 week, up 15.6% after 1 month and down 43.9% to date (from the $5.53 close on Jun 11, 2026).
CLNN
Clene Inc.
Key Points
- Morgan Brown, the CFO of CLNN, purchased 15,000 shares on June 11, 2026, at no cost per share.
- Shares of CLNN traded near $5.78, with insider buying suggesting confidence in the company's prospects.
- Analysts like HC Wainwright & Co. and D. Boral Capital maintain a 'buy' rating with targets up to $48.
Get $CLNN trade alerts by text
We text you when insiders, Congress or big funds trade $CLNN. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Clene Inc. alert may contain errors. Disclosures
Morgan Brown, the Chief Financial Officer of CLNN, made a notable move by purchasing 15,000 shares of the company on June 11, 2026. The shares were acquired at no cost, reflecting an insider's confidence in the company's future.
Other Institutional Activity in CLNN
BOXER CAPITAL MANAGEMENT, LLC significantly increased its stake in CLNN by adding 277,778 shares, ending with 477,515 shares worth about $2.35 million. In contrast, SYMBIOSIS CAPITAL PARTNERS, LLC reduced its holdings by 339,401 shares, leaving it with 431,094 shares valued at approximately $2.13 million. VANGUARD CAPITAL MANAGEMENT LLC entered the scene with 308,230 shares, valued at about $1.52 million. SCOGGIN MANAGEMENT LP also increased its position by 25,000 shares, totaling 300,000 shares worth $1.48 million. Meanwhile, ENSIGN PEAK ADVISORS, INC boosted its holdings by 143,511 shares to 257,872 shares, valued at $1.27 million.
Insider Buying and Selling at Clene Inc.
In addition to Morgan Brown's purchase, several other insiders made significant buys on June 11, 2026. Mark Mortenson, the Chief Science Officer, bought 45,000 shares, while President & CEO Robert Dee Etherington acquired 65,000 shares. Earlier, on May 21, 2026, Shalom Jacobovitz, Arjun JJ Desai, and David Matlin also bought shares, with each purchasing between 3,658 and 5,159 shares.
Analysts Set New Price Targets
On May 4, 2026, HC Wainwright & Co. reiterated its 'buy' rating for CLNN with a price target of $31. D. Boral Capital also maintained its 'buy' rating, setting a target of $23 on the same day. Canaccord Genuity maintained its 'buy' stance with a higher target of $48 back on March 13, 2026. The consensus among analysts is a 'buy' recommendation, with an average target price reflecting optimism in the stock's potential.
Bottom Line
The insider buying activity at CLNN, led by CFO Morgan Brown, suggests a strong vote of confidence in the company's future. Institutional movements also indicate varied strategies among major players, with some increasing and others reducing their stakes. Analysts remain bullish, maintaining 'buy' ratings with targets suggesting substantial upside. As always, it's important to remember that insider transactions and analyst ratings are just pieces of the overall investment puzzle.
Related Filing Alerts
Source: Morgan Brown's Form 4 filing on $CLNN (Jun 11, 2026). Find the original filing: CLNN Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts